138 related articles for article (PubMed ID: 8789606)
21. Purification and characterization of a tripeptidyl peptidase I from human osteoclastomas: evidence for its role in bone resorption.
Page AE; Fuller K; Chambers TJ; Warburton MJ
Arch Biochem Biophys; 1993 Nov; 306(2):354-9. PubMed ID: 8215436
[TBL] [Abstract][Full Text] [Related]
22. [Tripeptidyl-peptidase I--distribution, biogenesis, and mechanisms of activation].
Gołabek AA
Postepy Biochem; 2006; 52(1):16-23. PubMed ID: 16869297
[TBL] [Abstract][Full Text] [Related]
23. The expression of tripeptidyl peptidase I in various tissues of rats and mice.
Koike M; Shibata M; Ohsawa Y; Kametaka S; Waguri S; Kominami E; Uchiyama Y
Arch Histol Cytol; 2002 Aug; 65(3):219-32. PubMed ID: 12389661
[TBL] [Abstract][Full Text] [Related]
24. Characterization of endopeptidase activity of tripeptidyl peptidase-I/CLN2 protein which is deficient in classical late infantile neuronal ceroid lipofuscinosis.
Ezaki J; Takeda-Ezaki M; Oda K; Kominami E
Biochem Biophys Res Commun; 2000 Feb; 268(3):904-8. PubMed ID: 10679303
[TBL] [Abstract][Full Text] [Related]
25. Purification and characterisation of a tripeptidyl aminopeptidase I from rat spleen.
Vines D; Warburton MJ
Biochim Biophys Acta; 1998 May; 1384(2):233-42. PubMed ID: 9659384
[TBL] [Abstract][Full Text] [Related]
26. Maturation of human tripeptidyl-peptidase I in vitro.
Golabek AA; Wujek P; Walus M; Bieler S; Soto C; Wisniewski KE; Kida E
J Biol Chem; 2004 Jul; 279(30):31058-67. PubMed ID: 15143070
[TBL] [Abstract][Full Text] [Related]
27. Characterization and inhibition of a cholecystokinin-inactivating serine peptidase.
Rose C; Vargas F; Facchinetti P; Bourgeat P; Bambal RB; Bishop PB; Chan SM; Moore AN; Ganellin CR; Schwartz JC
Nature; 1996 Apr; 380(6573):403-9. PubMed ID: 8602240
[TBL] [Abstract][Full Text] [Related]
28. Axonal transports of tripeptidyl peptidase II in rat sciatic nerves.
Chikuma T; Shimizu M; Tsuchiya Y; Kato T; Hojo H
Neurochem Int; 2007 Jan; 50(1):236-42. PubMed ID: 17023090
[TBL] [Abstract][Full Text] [Related]
29. The lysosomal degradation of neuromedin B is dependent on tripeptidyl peptidase-I: evidence for the impairment of neuropeptide degradation in late-infantile neuronal ceroid lipofuscinosis.
Kopan S; Sivasubramaniam U; Warburton MJ
Biochem Biophys Res Commun; 2004 Jun; 319(1):58-65. PubMed ID: 15158442
[TBL] [Abstract][Full Text] [Related]
30. Tripeptidyl-peptidase II: Update on an oldie that still counts.
Tomkinson B
Biochimie; 2019 Nov; 166():27-37. PubMed ID: 31108122
[TBL] [Abstract][Full Text] [Related]
31. Tripeptidyl peptidase I, the late infantile neuronal ceroid lipofuscinosis gene product, initiates the lysosomal degradation of subunit c of ATP synthase.
Ezaki J; Takeda-Ezaki M; Kominami E
J Biochem; 2000 Sep; 128(3):509-16. PubMed ID: 10965052
[TBL] [Abstract][Full Text] [Related]
32. Inhibitor-based validation of a homology model of the active-site of tripeptidyl peptidase II.
De Winter H; Breslin H; Miskowski T; Kavash R; Somers M
J Mol Graph Model; 2005 Apr; 23(5):409-18. PubMed ID: 15781183
[TBL] [Abstract][Full Text] [Related]
33. Characterization of cDNA for human tripeptidyl peptidase II: the N-terminal part of the enzyme is similar to subtilisin.
Tomkinson B; Jonsson AK
Biochemistry; 1991 Jan; 30(1):168-74. PubMed ID: 1670990
[TBL] [Abstract][Full Text] [Related]
34. Identification of the catalytic triad in tripeptidyl-peptidase II through site-directed mutagenesis.
Hilbi H; Jozsa E; Tomkinson B
Biochim Biophys Acta; 2002 Dec; 1601(2):149-54. PubMed ID: 12445476
[TBL] [Abstract][Full Text] [Related]
35. Active site of tripeptidyl peptidase II from human erythrocytes is of the subtilisin type.
Tomkinson B; Wernstedt C; Hellman U; Zetterqvist O
Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7508-12. PubMed ID: 3313395
[TBL] [Abstract][Full Text] [Related]
36. Glycosaminoglycans modulate activation, activity, and stability of tripeptidyl-peptidase I in vitro and in vivo.
Golabek AA; Walus M; Wisniewski KE; Kida E
J Biol Chem; 2005 Mar; 280(9):7550-61. PubMed ID: 15582991
[TBL] [Abstract][Full Text] [Related]
37. Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis.
Rawlings ND; Barrett AJ
Biochim Biophys Acta; 1999 Jan; 1429(2):496-500. PubMed ID: 9989235
[TBL] [Abstract][Full Text] [Related]
38. Classical late infantile neuronal ceroid lipofuscinosis fibroblasts are deficient in lysosomal tripeptidyl peptidase I.
Vines DJ; Warburton MJ
FEBS Lett; 1999 Jan; 443(2):131-5. PubMed ID: 9989590
[TBL] [Abstract][Full Text] [Related]
39. Human dipeptidyl peptidase III acts as a post-proline-cleaving enzyme on endomorphins.
Barsun M; Jajcanin N; Vukelić B; Spoljarić J; Abramić M
Biol Chem; 2007 Mar; 388(3):343-8. PubMed ID: 17338643
[TBL] [Abstract][Full Text] [Related]
40. Specific localization of lysosomal aminopeptidases in type II alveolar epithelial cells of the rat lung.
Yayoi Y; Ohsawa Y; Koike M; Zhang G; Kominami E; Uchiyama Y
Arch Histol Cytol; 2001 Feb; 64(1):89-97. PubMed ID: 11310509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
